WASHINGTON — Executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novavax will testify Tuesday earlier than the Home Power and Commerce Committee’s oversight arm. The listening to, titled “Pathway to Safety: Increasing Availability of COVID-19 Vaccines,” will give lawmakers an opportunity to grill drug makers on why provide of Covid-19 vaccines remains to be so restricted — and what they’re doing to repair it.
Listed here are just a few of the burning questions STAT hopes lawmakers will ask.
What’s it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, coverage, and life science protection and evaluation.
Our award-winning crew covers information on Wall Avenue, coverage developments in Washington, early science breakthroughs and scientific trial outcomes, and well being care disruption in Silicon Valley and past.
What’s included?
- Day by day reporting and evaluation
- Essentially the most complete trade protection from a powerhouse crew of reporters
- Subscriber-only newsletters
- Day by day newsletters to temporary you on an important trade information of the day
- STAT+ Conversations
- Weekly alternatives to have interaction with our reporters and main trade consultants in stay video conversations
- Unique trade occasions
- Premium entry to subscriber-only networking occasions across the nation
- The very best reporters within the trade
- Essentially the most trusted and well-connected newsroom within the well being care trade
- And way more
- Unique interviews with trade leaders, profiles, and premium instruments, like our CRISPR Trackr.